| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,637 |
1,635 |
$115K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,648 |
1,470 |
$76K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,132 |
1,132 |
$73K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,021 |
864 |
$39K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
250 |
249 |
$31K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
65 |
65 |
$23K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
386 |
370 |
$19K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
775 |
679 |
$13K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
12 |
12 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
523 |
299 |
$4K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
700 |
387 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
311 |
309 |
$2K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
96 |
94 |
$774.75 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
113 |
107 |
$587.89 |
| 81003 |
|
383 |
376 |
$425.16 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
19 |
19 |
$84.18 |